ASBP
Aspire Biopharma·NASDAQ
--
--(--)
--
--(--)
ASBP fundamentals
Aspire Biopharma (ASBP) released its earnings on May 14, 2025: revenue was -- (YoY --), beat estimates; EPS was -- (YoY --), met estimates.
Revenue / YoY
--
--
EPS / YoY
--
--
Report date
May 14, 2025
Earnings
EPS
Revenue
Revenue & Expenses
ASBP has released its 2025 Q3 earnings report, with revenue of 1.94K, reflecting a YoY change of NaN%, and net profit of -1.85M, showing a YoY change of -755.64%. The Sankey diagram below clearly presents ASBP's revenue sources and cost distribution.
Key Indicators
Aspire Biopharma (ASBP) key financial stats and ratios, covering profitability, financial health, and leverage.
Income Statement
Aspire Biopharma (ASBP)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Balance Sheet
Aspire Biopharma (ASBP)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Cash Flow
Aspire Biopharma (ASBP)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Revenue Breakdown
Where does Aspire Biopharma (ASBP) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Dividend
Track Aspire Biopharma (ASBP) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield
You can ask Aime
What factors drove the changes in Aspire Biopharma's revenue and profit?What guidance did Aspire Biopharma's management provide for the next earnings period?What were the key takeaways from Aspire Biopharma’s earnings call?What is Aspire Biopharma's latest dividend and current dividend yield?What is the revenue and EPS growth rate for Aspire Biopharma year over year?What were the key takeaways from Aspire Biopharma's earnings call?Did Aspire Biopharma beat or miss consensus estimates last quarter?What is the market's earnings forecast for Aspire Biopharma next quarter?
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
